8 de diciembre de 2019
  • Sábado, 7 de Diciembre
  • Viernes, 6 de Diciembre
  • Jueves, 5 de Diciembre
  • 9 de diciembre de 2009

    Important Progress in Treatment of Early and Late Stage Breast Cancer With Herceptin, Avastin and T-DM1 (y 2)


    - Roche SABCS materials:
    http://www.roche.com/media/events/med-sabcs2009.htm

    - More about Roche's work in oncology:
    http://www.roche.com/media_backgrounder/media_oncology.htm

    - Oncology backgrounders:
    http://www.roche.com/media_backgrounder/media_oncology.htm

    - Roche.com section on PHC:
    http://www.roche.com/research_and_development/phc_in_r_d.htm

    - http://www.thenewsmarket.com

    - Video clips and backgrounder on products:
    http://www.roche.com/med-cor-2009-05-15.htm

    References ---------------------------------

    [i] Baselga J. et al., Abstract 1004. American Society of Clinical Oncology Annual Meeting 2007.

    [ii] Harries M, Smith I. The development and clinical use of trastuzumab (Herceptin). Endocr Relat Cancer 9: 75-85, 2002.

    Roche Group Media Relations: Phone: +41-61-688-8888 / e-mail: basel.mediaoffice@roche.com, Daniel Piller (Head), Alexander Klauser, Martina Rupp, Claudia Schmitt, Nina Schwab-Hautzinger